Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.

Autor: Catherine M Broome, Naushin Hooda, Jun Su, Xiaohui Jiang, Gina Nicholson, Cara L Frankenfeld, Melitza Iglesias-Rodriguez, Jon Fryzek, Parija Patel

Publikováno v: PLoS ONE, Vol 17, Iss 12, p e0276617 (2022)

BackgroundCold agglutinin disease (CAD) is a rare, chronic form of autoimmune hemolytic anemia. Clinical manifestations can include classical complement pathway-mediated chronic hemolysis, anemia, and profound fatigue. Research has shown that patient

Externí odkaz: https://doaj.org/article/cb3b3b0a83ed4c4bb9f570defff7c3e3

The epidemiology of desmoid tumors in Denmark

Autor: Marie Anneberg, Helene M.L. Svane, Jon Fryzek, Gina Nicholson, Jessica B. White, Badreddin Edris, L. Mary Smith, Naushin Hooda, Michael M. Petersen, Thomas Baad-Hansen, Johnny Ø. Keller, Peter H. Jørgensen, Alma B. Pedersen

Publikováno v: Anneberg, M, Svane, H M L, Fryzek, J, Nicholson, G, White, J B, Edris, B, Smith, L M, Hooda, N, Petersen, M M, Baad-Hansen, T, Keller, J Ø, Jørgensen, P H & Pedersen, A B 2022, ' The epidemiology of desmoid tumors in Denmark ', Cancer epidemiology, vol. 77, 102114 . https://doi.org/10.1016/j.canep.2022.102114

INTRODUCTION/AIM: The epidemiology, demographic, clinical, treatment, and healthcare resource utilization (HRU) characteristics of desmoid tumor (DT) patients treated at two sarcoma centers in Denmark is described.METHODS: Using Danish health registe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5ae7e584a4f0ccad9f0e45d1d18a0c9
https://doi.org/10.1016/j.canep.2022.102114

Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis

Autor: Feng Zeng, Timothy E Albertson, Laurence W. Busse, Cho Han Lee, Robert J. Nordyke, Gina Nicholson

Publikováno v: International journal of technology assessment in health care. 36(2)

BackgroundPatients with distributive shock who are unresponsive to traditional vasopressors are commonly considered to have severe distributive shock and are at high mortality risk. Here, we assess the cost-effectiveness of adding angiotensin II to t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24b330670a6c2065561edd5da78dfe9
https://pubmed.ncbi.nlm.nih.gov/32114996

Patient-level costs of major cardiovascular conditions: a review of the international literature

Autor: Ronald J. Halbert, Shravanthi R. Gandra, Gina Nicholson, Robert J. Nordyke, Akshara Richarriya

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Objective Robust cost estimates of cardiovascular (CV) events are required for assessing health care interventions aimed at reducing the economic burden of major adverse CV events. This review synthesizes international cost estimates of CV events. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd06d8265d4f12eda0d4df5acc50114c
https://doi.org/10.2147/ceor.s89331

Abstract 252: Champion Phoenix Study Economic Results: Direct Hospitalization Costs of Patients Receiving Clopidogrel or Cangrelor During Percutaneous Coronary Intervention

Autor: Duane S Pinto, Gina Nicholson, Robert A Harrington, Philip L Cyr, Deepak L Bhatt

Publikováno v: Circulation: Cardiovascular Quality and Outcomes. 7

Background: Current guidelines recommend use of antiplatelet agents (oral P2Y12 inhibitors and/or GPIIb/IIIa inhibitors) in combination with antithrombin agents (bivalirudin or heparins) for PCI. Cangrelor, a new, intravenous, rapid on/off-set P2Y12

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0216d671dda1d69980dffb69eb8cd772
https://doi.org/10.1161/circoutcomes.7.suppl_1.252